Article

Combining circulating tumor cell and circulating cell free DNA analyses enhances liquid biopsy sensitivity in detecting high grade serous tubo-ovarian carcinoma

2025-10-14

Abstract excerpt

<h4>Background</h4> Liquid biopsy is a promising strategy for detecting and monitoring neoplastic diseases, with circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) being the most common objects of investigation. Most analyses have focused on these biomarkers separately, and simultaneous detection has not yet been attempted in high grade serous tubo-ovarian carcinoma (HGSOC). The aim of our study was...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0429c52a-479c-59da-a28f-6a6d8d79dba9
DOI: 10.1101/2025.10.13.681971

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Combining circulating tumor cell and circulating cell free DNA analyses enhances liquid biopsy sensitivity in detecting high grade serous tubo-ovarian carcinomaDOI 10.1101/2025.10.13.681971Read

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial CancerSemantic proximity Read

Detecting TP53 mutations in paired liquid and tissue biopsies from patients with high-grade serous ovarian carcinoma.Semantic proximity Read

Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA.Semantic proximity Read

Concordance of Genomic Alterations in Ovarian Cancer Tissues and Circulating-Tumor DNA: A Pilot Study.Semantic proximity Read

High-Grade Serous Ovarian Cancer—A Risk Factor Puzzle and Screening FugitiveSemantic proximity Read

Circulating Tumor DNA in Genitourinary Malignancies: Current Applications and Future PerspectivesSemantic proximity Read

Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer.Semantic proximity Read

Advances in application of circulating tumor DNA in ovarian cancer.Semantic proximity Read

Identification of TP53 mutations in circulating tumour DNA in high grade serous ovarian carcinoma using next generation sequencing technologies.Semantic proximity Read

Circulating Tumor DNA (ctDNA) and Its Role in Gynecologic Malignancies.Semantic proximity Read

TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian CancerSemantic proximity Read

Multi-analyte approach combining cfDNA sequencing and protein testing for early ovarian cancer detectionSemantic proximity Read